Moderna Says Its COVID Vaccine Nearly 95% Effective

Moderna Says Its COVID Vaccine Nearly 95% Effective

From the Washington Post:

Biotechnology firm Moderna announced Monday that a preliminary analysis shows its experimental coronavirus vaccine is nearly 95 percent effective at preventing illness, including severe cases — a striking initial result that leaves the United States with the prospect that two coronavirus vaccines could be available on a limited basis by the end of the year.

The news comes a week after pharmaceutical giant Pfizer and its German partner BioNTech lifted the stock market and people’s hopes with the news that their coronavirus vaccine was more than 90 percent effective.

At a briefing Monday, government officials predicted that if the two vaccines receive a regulatory greenlight, the first shots could be given in December, with enough to vaccinate 20 million people that month — and more becoming available into 2021 as production ramps up and other vaccine candidates may be successful.

The news is extremely promising but researchers still have some questions including how long will the protection of the vaccine last?

Moderna has said it can produce 20 million doses by the end of the year — enough for 10 million people to get both shots.